Sulfuric Acid

Sulfuric Acid

SCHEMBL4417122

CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(CN)CC4)ccc3OCC)nc12.CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(CN)CC4)ccc3OCC)nc12.O=S(=O)(O)O

nearest known ligand 0.84

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1A known ✓ P35348 1/20 0.82
PDE5A O76074 20/20 0.84
PDE3B Q13370 3/20 0.84
PDE3A Q14432 3/20 0.84
PDE2A O00408 1/20 0.82
ABCC4 O15439 1/20 0.82
ABCC5 O15440 1/20 0.82
PDE6D O43924 1/20 0.82
PDE8A O60658 1/20 0.82
PDE9A O76083 1/20 0.82
ABCB11 O95342 1/20 0.82
CYP3A4 P08684 1/20 0.82
HTR1A P08908 1/20 0.82
PDE6A P16499 1/20 0.82
PDE6G P18545 1/20 0.82
PDE4A P27815 1/20 0.82
ADORA2A P29274 1/20 0.82
ADORA1 P30542 1/20 0.82
PDE6B P35913 1/20 0.82
PDE6C P51160 1/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7915874 0.98 PDE5A (0.88) PDE5APDE3BPDE3APDE2AABCC4
SCHEMBL30848678 0.92 PDE5A (0.95) PDE5APDE3BPDE3APDE2AABCC4
SCHEMBL5010426 0.92 PDE5A (0.90) PDE5APDE3BPDE3APDE2AABCC4
SCHEMBL29358004 0.92 PDE5A (1.00) PDE5APDE3BPDE3APDE2AABCC4
SCHEMBL17342850 0.92 PDE5A (1.00) PDE5APDE3BPDE3APDE2AABCC4
Lodenafil SCHEMBL1058 0.91 PDE5A (1.00) PDE5APDE3BPDE3APDE2AABCC4
Lodenafil SCHEMBL31202790 0.91 PDE5A (1.00) PDE5APDE3BPDE3APDE2AABCC4
SCHEMBL21682504 0.90 PDE5A (0.88) PDE5APDE3BPDE3APDE2AABCC4
Sildenafil SCHEMBL34463415 0.90 PDE5A (0.94) PDE5APDE3BPDE3APDE2AABCC4
Sildenafil SCHEMBL2112660 0.90 PDE5A (0.94) PDE5APDE3BPDE3APDE2AABCC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8524274-B2 Liposomal composition comprising an active ingredient for relaxing smooth muscle, the production of this composition and the therapeutic use thereof POLYMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNG GMBH (AT) 2013-09-03 US disclosed
US-20090324698-A1 LIPOSOMAL COMPOSITION COMPRISING AN ACTIVE INGREDIENT FOR RELAXING SMOOTH MUSCLE, THE PRODUCTION OF THIS COMPOSITION AND THE THERAPEUTIC USE THEREOF POLYMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNG GMBH (AT) 2009-12-31 US disclosed